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a b s t r a c t
Introduction: People with cancer frequently report limitation in Activities of Daily Living (ADLs); essential
activities required to live independently within society. Although several studies have assessed ADL
related disability, variability in assessment, setting, and population means evidence is difficult to inter-
pret. We aimed to determine the prevalence of ADL related disability, overall and by setting, and the most
commonly affected ADLs in people living with cancer.
Methods: We searched twelve databases to June 2016 for observational studies assessing ADL disability
in adults with cancer. Data on study design, population, ADL instruments and disability (difficulty with or
requiring assistance in 1 activity) were extracted, summarised, and pooled to estimate disability preva-
lence with 95% confidence intervals (95% CI) overall and by setting.
Results: Forty-three studies comprising 19,246 patients were included. Overall, 36.7% (95% CI 29.8–44.3,
18 studies) and 54.6% (95% CI 46.5–62.3, 15 studies) of patients respectively reported disability relating to
basic and instrumental ADLs. Disability was marginally more prevalent in inpatient compared to outpa-
tient settings. The Katz Index (18 studies) and Lawton IADL Scale (11 studies) were the most commonly
used instruments. Across the activities studied, the most frequently affected basic ADLs were personal
hygiene, walking and transfers, and instrumental ADLs were housework, shopping and transportation.
Conclusions: About one-third and half of adults with cancer respectively have difficulty or require assis-
tance to perform basic and instrumental ADLs. These findings highlight the need for rehabilitation
focused on functional independence, and underscore the importance of professionals skilled in occupa-
tional assessment and therapy within cancer services.
 2017 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
With advances in screening and therapies, people are increas-
ingly living longer with the consequences of cancer and its treat-
ment. Patients with cancer frequently report a sustained
symptom burden, exercise intolerance, and physical decondition-
ing, all of which can threaten everyday independence [1]. Activities
of daily living (ADLs) refer to the essential activities an individual is
required to perform to live independently within society [2,3].
Activities are categorized into basic ADLs; referring to personal
care activities such as feeding, toileting, washing, and dressing,
as well as instrumental ADLs; referring to extended tasks such as
meal preparation, using public transportation, doing household
chores, and grocery shopping [4–7]. Performing ADLs is necessary
to maintain independent living, well-being and health related
quality of life [2,8,9]. Disability relating to ADLs (difficulty with
or requiring assistance in at least one activity) has been associated
with poorer quality of life, and in older adults is predictive of mor-
tality [10]. It follows therefore, that where disability relating to
ADLs exists, addressing it should be a core goal of clinical
management.
Although multiple studies assessing ADL disability in cancer
have been published, the variability among study populations, set-
tings, and measures makes it difficult to interpret the evidence.
Landmark studies have used ADL disability to characterise func-
tional decline at the end of life, for example Lunney et al. [11]
observed rapid disability following a high level of ADL perfor-
mance, and Gill et al. [12] demonstrated more varied trajectories
of disability. Whilst these studies highlight the severe impact of
https://doi.org/10.1016/j.ctrv.2017.10.006
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cancer on ability to manage ADLs, both were limited to a commu-
nity setting and late phase of illness. Earlier in the cancer trajec-
tory, individuals tend to experience more disability in
instrumental ADLs compared to basic ADLs [13,14], which supports
the notion that instrumental ADLs require a higher level of func-
tional ability [15]. Evidence regarding which activities are most
commonly affected in cancer questions the original hierarchy of
ADL proposed by Katz. For example, both eating [16] and bathing
[13] are commonly affected by cancer, despite these tasks being
considered the easiest and most difficult ADLs respectively [5,17].
To our knowledge, no review has systematically examined ADL-
related disability in adults living with cancer. A better understand-
ing of disability profiles and patterns regarding ADLs, including in
the context of cancer stage and settings, would allow clinicians to
target rehabilitation interventions, shape policy around rehabilita-
tion services, and equip researchers with a knowledge base on
which to develop treatments to reduce ADL disability. This review
aimed to identify instruments, items, and reporting of ADL disabil-
ity in people with cancer; to determine the prevalence of ADL dis-
ability overall and by setting; and describe the most commonly
affected basic and instrumental ADLs in this group.
Method
Design
The systematic review was planned in accordance with the Cen-
tre for Reviews and Dissemination [18] guidance on conducting
reviews and reported in accordance with the Preferred Reporting
Items for Systematic Reviews and Meta-Analysis (PRISMA) state-
ment [19].
Inclusion and exclusion criteria
Studies of adult populations (18 years), with a primary clinical
or histological diagnosis of cancer were included. Studies of paedi-
atric populations (<18 years) were excluded as they are recognized
as a distinct population with different ADL requirements from
adults. Cancer survivors were also excluded as the term survivor
has been defined in multiple ways, from those living with cancer
to those cured and free of any disease [20]. Studies employing
any measure of ADL disability were included. We did not consider
studies only employing measures of global functional status, e.g.
ECOG Performance Status, or physical limitation, e.g. walk tests.
All prospective and retrospective observational study designs were
eligible, including cohort studies, cross-sectional studies, longitu-
dinal studies, case series, and chart reviews.
Search strategy
An electronic search strategy using a combination of full-text
search terms and MeSH terms was developed for MEDLINE and
adapted where necessary for all other databases. Search terms
included ‘‘cancer” or ‘‘carcinoma” AND ‘‘functional disabilities”,
‘‘functional outcomes” or ‘‘functional impairment” AND ‘‘observa-
tional studies”, ‘‘cohort studies” or ‘‘longitudinal studies” All search
terms were used as full-text, with use of truncation symbol to
retrieve variations in the terminology. (Supplement, Appendix 1.)
A systematic literature search was conducted in 12 electronic
databases from inception to June 2016: MEDLINE; EMBASE;
CINAH; ASSIA (Applied Social Sciences Index and Abstracts); Psy-
chINFO; Social Policy and Practice; IBBS (International Bibliogra-
phy of the Social Science); Science Direct; Social Service Abstract;
Sociological Abstract; Scopus; Web of Science Core Collection. Grey
literature was searched on six databases: OpenGrey (System for
Information on Grey Literature); ProQuest Dissertations & Theses;
Web of Science Conference Proceedings; Scopus Conference Pro-
ceedings; HMIC (Health Management Information Consortium);
Global Health. No time restrictions were applied. Restrictions were
applied to studies in human subjects published in English
language.
Search alerts were set up regularly for updates of relevant new
publications in each database up to November 2016, and hand
searching was conducted up to October 2016. The first author (J.
N.) scanned reference lists, and performed forward and backward
citation tracking of included studies. Experts in the field of cancer
and disability were also contacted via email to seek potentially rel-
evant research material, including ongoing and unpublished
research.
Data collection and analysis
Selection of studies
An online reference management system (Refworks) was used
to manage electronic database hits and remove duplicates. Eligibil-
ity criteria were first applied to the title and abstracts. Full-text
articles were retrieved for titles/abstracts that meet the review cri-
teria or when information in the title and abstract was insufficient
to determine eligibility. The appraisal of articles against inclusion
and exclusion criteria was agreed between the first (J.N.) and last
(M.M.) authors, with any disagreements regarding the studies
resolved via discussion.
Assessment of methodological quality in included studies
Studies selected for inclusion of specific items of ADL disability
were assessed for methodological quality using Loney’s critical
appraisal tool [21], designed to assess quality and susceptibility
to bias in articles determining the incidence or prevalence of a clin-
ical issue. The tool covers eight criteria; description of study sub-
jects, random sample, unbiased sampling frame, adequate sample
size, standardised measures, unbiased assessors, adequate
response rate, and confidence intervals and subgroup analysis. A
point is allocated for the presence of each criterion. A higher score
indicates higher methodological quality.
Data extraction and analysis
A standardised data extraction form was developed, piloted,
and data from eligible studies was extracted (J.N. and M.M) to
retrieve data on study design, setting, sample characteristics,
instruments of ADL disability, and characteristics of ADL related
disability.
Normally distributed variables were summarised by mean and
standard deviation. For studies with multiple subgroups within
the sample, data were aggregated into a single group using the for-
mula devised by the Cochrane Collaboration for combining means
and standard deviations of groups [22]. Where mean was not
reported, mean and standard deviation was estimated from its
median and range using the formula devised by Hozo and col-
leagues [23]. When the range was not available for calculation of
mean, median was assumed as mean for studies of sufficiently
large sample size. Categorical variables e.g. cancer type, were sum-
marised by percentage of participants in the highest occurring
category.
Data on overall and specific ADL disability prevalence were
summarised by mean and 95% confidence intervals calculated
using Wilson’s method (Confidence Interval Analysis version
2.1.2 software). Disability prevalence was determined overall,
and by inpatient/outpatient setting as patients admitted to hospi-
tal or care home might be more dependant in ADLs. Data on num-
ber of ADL disability and total ADL disability score were
summarised as mean and standard deviations. Figures were
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produced using Graphpad Prism software 7.0b. A meta-analysis
was conducted to synthesise the results from multiple studies into
a single prevalence point for disability relating to basic and instru-
mental ADLs, overall and by setting, using Cochrane Collaboration’s
RevMan software [22].
Results
Study retrieval
Our search of the literature retrieved 13,432 articles. After de-
duplication and title/abstract screening, 83 full-text articles were
retrieved for further appraisal, of which 43 separate studies were
included (Fig. 1, see Supplement, Appendix 2 for excluded studies).
All studies were included for narrative review of instruments and
items of ADL disability. Data from eighteen and fifteen studies
respectively were used for meta-analyses for pooled estimates of
basic ADL and instrumental ADL disability.
Characteristics of included studies and sample participants
See Table 1 for information on characteristics of all included
studies. Most studies were conducted from 2000 onwards
(n = 32), in the US and Canada (n = 21), Europe (n = 19), or Asia
(n = 3). The majority of studies (n = 24) recruited participants from
outpatient settings, e.g. home care, clinics, or community-dwelling
adults. Data from a total of 19,246 participants were available, with
individual study samples sizes ranging from 45 to 6822.
Participants were heterogeneous with regards to primary cancer
type (breast, colorectal, lung, gastrointestinal, etc.) and cancer
treatment status.
Fig. 1. PRISMA flow diagram.
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Table 1
Characteristics of included studies for narrative review.
First author/year/
country
Study design Setting ADL outcome measures Sample characteristics
Sample
size (n)
Age
Mean ± SD
(years)
Male
(%)
Ethnicity (%) Cancer type (% of
sample)
Cancer stage (%
of sample)
PS (%) Treatment
(%)
Bentley
2013
UK [24]
Cross-sectional Outpatient Occupational Performance
Problem List
260 71 ± 10 62 White (90) NSCLC (81) NSCLC IV (55) ECOG 0 (28) Palliative
(79)
Chen
2007
USA [25]
Retrospective cohort Inpatient MDS – ADL 63 91 ± 6 33 ns ns ns ns ns
Cheville
2008
USA [26]
Cross-sectional Outpatient OARS – ADL and IADL 163 56 ± 1 0 White (71) Breast (100) IV (26) ns ns
Cole
2000
USA [27]
Retrospective case
series
Inpatient FIM
Motor Measure
200 71 ± 12 46 ns Blood-related (17)
Lung (17)
III (72) ns Curative (76)
Corsonello
2010
Italy [28]
Observational Inpatient Katz ADL 1398 65–79
years (45%)
63 ns GI (30) NA ns ns
Deckx 2015 Belgium;
Netherlands
[29]
Prospective
observational cohort
Inpatient Katz ADL
Lawton IADL
134 77.1b 21 ns Breast (69) II (54) ns Surgery (93)
Deeg
2005
Netherlands [30]
Prospective
longitudinal
Outpatient OECD – 3 activities 254 ns ns ns ns ns ns ns
de Miguel Sánchez
2006
Spain [31]
Prospective
longitudinal
Outpatient Katz ADL 98 72 ± 12 61 ns GI (28) Metastases (87) PPS score 50
(33)
ns
Derks
2004
Netherlands [32]
Prospective
longitudinal
Outpatient ADL and IADL
questionnaires
121 45–60
years (61%)
64 ns Oral cavity (46) ns KPS 90–100
(87)
Surgical (76)
Echteld
2004
Netherlands [33]
Prospective
longitudinal
Inpatient RAI-MDS-PC 355 73 ± 13 45 ns Lung (20) ns ns ns
Extermann
1998
USA [34]
Prospective cohort Outpatient Katz ADL
Lawton IADL
203 76 ± 8a 39 ns Breast (34) Metastatic (47) ECOG 1 (53) ns
Finalyson
2012
USA [35]
Retrospective cohort Inpatient MDS – ADL 6822 83 ± 8 32 White (86) ns ns ns ns
Flood
2006
USA [36]
Retrospective
descriptive
Inpatient Katz ADL
Lawton IADL
96 (Katz
ADL)
91
(Lawton
IADL)
74 ± 6 48 White (77) Lung (30) ns ns ns
Gill
2010
USA [12]
Longitudinal Outpatient 4-item ADL questionnaire 74 82 ± 5 39 White (91) ns ns ns ns
Girones
2012
Spain [37]
Prospective Outpatient 5-item Katz ADL
Lawton IADL
83 77 ± 5 98 ns NSCLC (76) III (41) ECOG 1 (40) ns
Given
1994
USA [38]
Prospective
longitudinal
Outpatient Katz ADL Lawton IADL 111 63 ± 7 50 ns GI (29) ns ns CT + Other
(78)
(continued on next page)
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Table 1 (continued)
First author/year/
country
Study design Setting ADL outcome measures Sample characteristics
Sample
size (n)
Age
Mean ± SD
(years)
Male
(%)
Ethnicity (%) Cancer type (% of
sample)
Cancer stage (%
of sample)
PS (%) Treatment
(%)
Greimel
2000
Austria [39]
Prospective Outpatient ALLTAG 98 56 ± 13a 0 ns Cervical (47) ns ns Surgery (51)
Guadagnoli
1991
USA [40]
Cross-sectional Outpatient Telephone interviews on
ADL/IADL
413 65–75
years (29%)
29 White (98) Breast (47) ns ns Palliative
(63)
Hamaker
2011
Netherlands [41]
Prospective
observational cohort
Inpatient Katz ADL
Modified Katz IADL
292 78 ± 9a 51 ns ns Metastases (43) ns ns
Huijberts
2016
Netherlands [42]
Prospective cohort Inpatient Modified Katz ADL 151 76 ± 7 46 Dutch (91) ns ns ns ns
Hunter
2012
USA [43]
Retrospective Inpatient FIM Motor Measure 215 61 ± 16 49 ns ns ns ns ns
Hurria
2006
USA [44]
Prospective
longitudinal
Outpatient Katz ADL
Lawton IADL
50 71 ± 6a 51 White (80) Breast (100) IIA (49) ns Lumpectomy
(63)
Kanesvaran
2014
China [45]
Prospective Inpatient 5-item ADL questionnaire
OARS – IADL
803 76 ± 8a 60 Han (95) Lung (33) IV (56) ns CT (44)
Kim
2011
Korea [46]
Prospective Outpatient MBI
Lawton IADL
65 72 ± 4a 75 ns Colorectal (34) IV (49) ECOG 0–1
(89)
Palliative CT
(74)
Korouklian
2010
USA [47]
Retrospective
database review
Outpatient ADLs recorded in the OASIS 1009 75–79
years (26%)
43 Non-African
American (92)
Colorectal (100) Localised (74) ns ns
Lindahl-Jacobsen
2015
Denmark [48]
Cross-sectional Inpatient ADL – Q 118 70 ± 10 35 ns Lung (29) ns KPS score
50–70 (86)
ns
Lindsey
1994
USA [49]
Prospective
longitudinal
Outpatient FAI ADL and IADL 45 72 ± 7a 36 White (91) Lung (57) ns ns ns
Luciani
2008
USA [50]
Retrospective cross
sectional
Outpatient Katz ADL
Lawton IADL
214 79 ± 5 37 ns ns ns ECOG 0 (62) ns
Lunney
2003
USA [11]
Prospective
longitudinal
Outpatient Interview on 7 ADLs 897 78 ± 7 63 White (80) ns ns ns ns
Marcinak
1996
USA [51]
Retrospective case
series
Inpatient FIM Motor Measure 159 57 ± 17 49 ns Primary
intracranial (45)
ns ns Surgery (86)
McCarthy
2000
USA [52]
Prospective cohort Outpatient 7-item Modified Katz Index
ADL
1063 64 ± 8a 61 White (84) NSCLC (70) ns ns CT (61)
McEwen
2012
Canada [53]
Retrospective record
review
Inpatient FIM Motor Measure 153 73 ± 13 41 ns Colorectal (29) ns ns ns
Movsas
2003
USA [54]
Prospective cohort Inpatient FIM Motor Measure 55 61 ± 17a ns ns Hematologic (40) Metastatic (69) ns ns
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O’Hare
1993
USA [55]
Longitudinal Outpatient ESDS 63 65 years
(48%)
38 ns ns ns ns ns
Ögce
2008
Turkey [56]
Longitudinal
descriptive
Outpatient IFS-CA 101 >50 years
(50%)
0 ns Breast (100) Localised (52) ns Mastectomy
(98)
Repetto
2002
Italy [57]
Prospective
cross-sectional
Inpatient Katz ADL
Lawton IADL
363 76 ± 8a 46 ns Breast (31) Localised (40) ECOG < 2
(74)
ns
Retornaz
2007
France [58]
Retrospective chart
review
Outpatient Katz ADL
4-item IADL scale
144 79 ± 7 46 ns Breast (18) Metastases (75) ns None (58)
Retornaz
2008
France [59]
Retrospective chart
review
Inpatient Katz ADL
4-item IADL scale
186 80 ± 7 48 ns Breast (15) Metastases (71) ns None (46)
Serraino
2001
Italy [60]
Cross-sectional Inpatient Katz ADL
Lawton IADL
303 76 ± 8a 60 ns Haematological
neoplasia (60)
ns ECOG 0–1
(62)
ns
Silver
2010
Brazil [61]
Prospective
longitudinal
Outpatient Katz ADL
6-item Lawton IADL
60 61 ± 12 88 White (95) Mouth (40) IV (35) ns Surgery (82)
RT (82)
Stafford
1997
USA [62]
Cross-sectional Outpatient 6-item ADL questionnaire
6-item IADL questionnaire
1647 75b 33 ns Breast (24) ns ns ns
Tay
2009
Singapore [63]
Prospective cohort Inpatient FIM 58 57 ± 16 62 ns Solid tumour (86) ns ns RT (25.9)
Ulander
1997
Sweden [64]
Exploratory Outpatient Katz Index and Hulter-
Asberg’s IADL index
86 70 ± 13 54 ns Colorectal (100) Metastases (44) ns ns
All values rounded to the nearest whole number.
ns = not stated.
Abbreviations: ADL: Activities of Daily Living; ADL – Q: Activities of Daily Living Questionnaire; CT: Chemotherapy; ECOG: Eastern Cooperation Oncology Group; GI: Gastrointestinal; IADL: Instrumental Activities of Daily Living;
KPS: Karnofsky Performance Status; NHS: National Health Service ; ns; not specified; NSCLC: Non squamous cell lung carcinoma; OT: Occupational therapy; PCU: Palliative Care Unit; RAI – MDS – PC: Resident Assessment
Instrument – Minimum Data Set – Palliative Care; RAI-PC: Inter Resident Assessment Instrument - Palliative Care; PPS: Palliative Performance Scale; PS: Performance status; SF-36: 36-Item Short Form Health Survey.
a Means estimated using median, range, and sample size Hozo et al. [23].
b SD not specified in study
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Instruments, items and reporting of ADL disability
In all studies, ADL disability was defined as having difficulty
with or requiring assistance in at least one activity. Most studies
used standardised and validated instruments, however, close to
one-quarter of studies (n = 9/43) used questionnaires and/or scales
constructed specifically for the study, with items from a parsimo-
nious selection of ADL. The most commonly used ADL instruments
were the Katz Index of Independence to assess basic ADLs (n = 18),
and the Lawton IADL scale (n = 11) to assess for instrumental ADLs.
For both measures, deviation from the standardised protocol, with
use of fewer or additional question items was commonly observed.
Methodological quality assessment
For articles reporting the prevalence of disability in specific
items of ADL, the median (range) methodologic score was 5 (4–
6) out of a possible 8. Participant characteristics were generally
adequately described, whilst the participation response rate and
characteristics of patients declining participation were less fre-
quently reported. A post-hoc decision was made not to use quality
criteria in any sensitivity analysis due to the heterogeneity across
studies.
ADL disability in adults with cancer
Disability relating to basic ADLs
Eighteen studies provided information about performance of
basic ADLs. The mean [95% CI] prevalence of disability was 36.7%
[29.8–44.3] for the overall population (see Fig. 2). There was a wide
range of prevalence estimates for basic ADL disability across both
inpatient (14–53%) and outpatient settings (0–86%) and significant
heterogeneity across study-specific estimates (I2 96% for both,
p < .001). The pooled mean estimate was not statistically different
according to setting (inpatient 32.0% [24.0–41.3] vs. outpatient
41.2% [31.2–51.9], p = .19).
Disability relating to instrumental ADLs
Fifteen studies provided information about instrumental ADLs.
The mean [95% CI] prevalence of disability was 54.6% [46.5–62.3]
for the overall population (see Fig. 2). Again, there was a wide
range of prevalence estimates for disability across both inpatient
(44–77%) and outpatient settings (13–75%) and significant
heterogeneity across study-specific estimates (I2 91 and 97%, both
p < .001). The pooled mean estimates of disability according to
study setting were borderline statistically different (inpatient
62.8% [55.2–69.8] vs. outpatient 46.1% [31.9–61.0], p = .05).
Number of ADLs affected and ADL disability scores
In the inpatient setting, the number of basic ADLs requiring
assistance ranged from 4.7 to 5.0, and instrumental ADLs ranged
from 3.0 to 4.7. In the outpatient setting, the number of basic ADLs
requiring assistance ranged from 0.6 to 4.0, and instrumental ADLs
ranged from 0.9 to 3.1 (Table 2). Seventeen studies provided mean
total scores using a standardised instrument, which may be useful
to inform future trial design. Study specific estimates from com-
monly used instruments across different cancer types, stages, and
clinical settings are shown in Table 3.
Disability in specific ADLs
Among eight basic ADLs assessed, disability relating to personal
hygiene was the most prevalent, followed by disability related to
walking, transfers, and bathing. In four of the studies on walking,
two reported a prevalence of disability  50%. The least affected
activities were eating and stair climbing (Fig. 3). Among eight
instrumental ADLs assessed, disability relating to housework was
most prevalent, followed by disability related to shopping and
transportation. Where performance in housework was assessed,
four of six studies found  50% of patients reporting disability.
The least affected activities were telephone use, handling finances,
and medication management (Fig. 4).
Discussion
This systematic review of 43 observational studies, with 19,246
patients, reveals that about one-third of adults with cancer respec-
tively require assistance to perform basic ADLs and about one-half
require assistance to perform instrumental ADLs. Although a wide
range of instruments, item and scales were used, our analysis of
specific ADLs demonstrates that limitations most frequently
related to the basic ADLs of personal hygiene, walking and transfer,
and the instrumental ADLs of housework, shopping and trans-
portation. Our findings highlight substantial need for rehabilitation
services that focus on maintaining functional independence, and
underscore an important role for professionals skilled in occupa-
tional assessment and therapy.
Measurement of ADL disability
The most common instruments in measuring ADL disability
were the Katz Index of Independence in ADL and the Lawton IADL
Scale. Some studies included fewer or additional ADL items using
modifications of these standardised measures. A small but signifi-
cant proportion of studies utilised questionnaire of selected ADL
items. The use of selected items to assess ADL performance has
been advocated for in clinical practice. Roehrig and colleagues
[65] recommended geriatricians to use six ADL items instead of
18 items when conducting screening assessment of frail older peo-
ple. This recommendation was made based on analysis of ADL data
from 327 patients entered into a forward selection model. Six ADL
items were sensitive in identifying 98.5% of patients with ADL
related disability. Deviations from the use of standardised mea-
sures and use of self-constructed questionnaires are stumbling
blocks to the advancement of science in the study of disability,
as data on ADL disability could not be compared across studies
or pooled together to increase power.
Reporting of ADL related disability
All the studies used dependency, defined as having difficulty to
do an activity or having someone’s help in at least one ADL, as an
indicator of disability. A measure of dependency provides an indi-
cator of disability, but is not a measure of disability itself [7]. Dis-
ability is often measured by the degree of difficulty (none, some, a
lot, unable) or the level of help needed (minimum assistance, mod-
erate assistance, maximum assistance) with a task. Much informa-
tion about the severity of disability is therefore lost when a
measure of dependency is used. Verbrugge and Jette’s [7] critiqued
that whilst dependency measures the need for an intervention to
reduce disability, it is not discriminative in capturing the charac-
teristics of disability, and therefore not able to provide patient-
specific information about rehabilitation needs or home care sup-
port needs.
Characteristics of ADL related disability
Prevalence of ADL disability
ADL related disability was highly prevalent among adults living
with cancer. Approximately one-third (37%) and half (55%) of those
studied experienced difficultly of required assistance to complete
basic and instrumental ADLs respectively. These findings are not
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unexpected as literature has previously discussed the severe
impact of cancer and its treatment on ADL performance. For exam-
ple, Mohile et al. [14] and Stafford et al. [62] found 41% and 44% of
older community-dwelling people with cancer experienced diffi-
culty with at least one ADL. Given the high incidence of cancer
worldwide, and the resultant inability to manage ADLs, manage-
ment of ADL related disability should arguably be a core part of
oncology practice.
There was significant heterogeneity across study-specific preva-
lence estimates for disability relating to basic and instrumental
ADLs. This finding likely relates to differences in the characteristics
of each study. A systematic review by Harrison et al. [66] on care
Fig. 2. Prevalence of disability in basic and instrumental ADL by study. Red lines indicate inpatient settings and black lines outpatient settings.
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needs at different phases of cancer experience found unmet care
needs in ADL ranged widely (1–73%). Further analysis showed that
care needs for ADLs changed according to the point in the cancer
trajectory: at diagnosis (5–10%), during treatment (5–73%), post-
treatment (41–47%); and during the terminal stages of illness (1–
52%). This heterogeneity sheds new light on the controversy sur-
rounding the impact of cancer and its treatment on ADLs, which
warrants further study.
ADL disability higher in inpatients than outpatient
The prevalence of disability related to instrumental ADLs was
higher in studies of inpatients compared to outpatients. Similarly,
Retornaz et al. [58] found 75% of 144 older people with cancer
admitted to hospital with instrumental ADL disability while Jolly
et al. [67] found only 23% of similar but community-dwelling
group reported disability. One would expect more disability in
inpatients as the inability to perform instrumental ADLs at home
may be one reason for admission [68]. Such information may be
useful to plan and evaluate strategies to prevent disability in out-
patient oncology settings.
A hierarchical relationship in ADL
The most commonly affected basic ADL was personal hygiene,
such as grooming and brushing teeth, though this finding should
Table 2
Characteristics of studies and number of ADL disabilities.
First author Clinical setting ADL outcome measures Basic ADL
(mean ± SD)
Instrumental ADL
(mean ± SD)
Retornaz
2008 [59]
Inpatient 6-item Katz ADL
4-item IADL scale
5.0 ± 2.3a 3.0 ± 1.6a
Cheville
2008 [26]
Outpatient OARS – 7-item ADL and 7-item IADL 1.8 ± 0.8 2.4 ± 2.1
Girones
2012 [37]
Outpatient 5-item Katz ADL
6-item Lawton IADL
4.0 ± 1.0 3.0 ± 2.0
Lunney
2003 [11]
Outpatient Interview on 7 ADLs 0.7c ns
McCarthy
2000 [52]
Outpatient 7-item Modified Katz ADL 1.3b ns
Silver
2010 [61]
Outpatient 6-item Katz ADL
6-item Lawton IADL
0.6 ± 1.7 3.1 ± 3.3
Stafford
1997
Outpatient 6-item ADL questionnaire
6-item IADL questionnaire
1.0c 0.9c
All values rounded to nearest decimal place.
Abbreviations: ADL: Activities of Daily Living; IADL: Instrumental Activities of Daily Living; ns; not stated; OARS: The Older Americans Resource and Services
a Median was reported in study, and assumed as mean.
b Median was reported in study, and assumed as mean. Multiple groups were combined into one group using Cochrane formula.
c SD not specified.
Table 3
Characteristics of studies and total ADL disability score.
First author Clinical setting ADL outcome measures Range Basic ADL (mean ± SD) Instrumental ADL (mean ± SD)
Chen
2007 [25]
Inpatient MDS – ADL 0–28 12.6 ± 9.6 ns
Cole
2000 [27]
Inpatient FIM Motor Measure 0–100 43.7 ± 6.3a ns
Finalyson
2012 [35]
Inpatient MDS – ADL 0–28 12.7 ± 8.2 ns
Flood
2006 [36]
Inpatient Katz Index
Lawton IADL
6–18
8–21
13.1 ± 2.7 19.7 ± 5.0
Hunter
2012 [43]
Inpatient FIM Motor Measure 13–91 61 ± 17 ns
Marcinak
1996 [51]
Inpatient FIM Motor Measure 0–100 42.6b ns
McEwen
2012 [53]
Inpatient FIM Motor Measure 13–91 58.0 ± 10.6 ns
Movsas
2003 [54]
Inpatient FIM Motor Measure 13–91 72.0 ± 14.0 ns
Tay
2009 [63]
Inpatient FIM 18–126 70.9 ± 18.0 ns
Lindsey
1994 [49]
Outpatient FAI ADL and IADL 13–26
15–29
25.5 ± 1.2 28.2 ± 1.5
Cheville
2009 [26]
Outpatient FIM Mobility scale 5–35 30.2 ± 5.8 ns
Derks
2004 [32]
Outpatient ADL and IADL questionnaires ns 19.9a,b 17.5a,b
Hurria
2006 [44]
Outpatient 6-item Katz ADL
Lawton IADL
6–18
8–21
18.0b 21.0b
All values rounded to nearest decimal place. For all outcome measures, except MDS-ADL, a lower score reflects dependence, while a higher score reflects independence.
Abbreviations: ADL: Activities of Daily Living; FAI: Functional Assessment Inventory; FIM: Functional Independence Measure; MDS – ADL: Minimum Data Set Activity of Daily
Living; IADL: Instrumental Activities of Daily Living; IFS – CA: Inventory of Functional Status-Cancer; ns; not stated; OECD: Organisation for Economic Co-operation and
Development.
a Means combined from multiple samples using Cochrane formula for combing groups.
b SD not specified in study.
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be interpreted with caution as the activity was only assessed in one
study. Walking and transfers were also commonly affected and
these finding corroborate previous studies [14,62]. Many clinicians
would intuitively agree as walking and transfers as mobility tasks
are physically demanding. The least affected basic ADL was eating,
consistent with the order of loss in ADL functions proposed by Katz
and colleagues [5,17].
Concerning instrumental ADLs, household management was
most commonly affected, exemplified by the findings from Mohile
et al. and Stafford et al. [14,62]. In general, instrumental ADLs
requiring physical function were more commonly affected than
those requiring cognitive functions. This may represent a bias in
the selection and recruitment of patients into studies, e.g. exclud-
ing those without capacity to consent, but may reflect that patients
Fig. 3. Prevalence of disability in specific basic ADLs. Red lines indicate inpatient settings and black lines outpatient settings.
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Fig. 4. Prevalence of disability in specific instrumental ADLs. Red lines indicate inpatient settings and black lines outpatient settings.
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still perform cognitive tasks despite the loss of physical functions.
Engaging patients in cognitive activities to maintain independence
in instrumental ADL is encouraged.
Strengths and limitations
There are several strengths to this review. We developed a
detailed protocol that ensured consistency and transparency in
the review processes. Publication bias was minimised by utilising
more than one source of information and methods to locate pub-
lished and unpublished studies. Our searches were not restricted
to a certain discipline and spanned health and social care data-
bases. We also took steps to minimise judgment errors and bias,
with authors’ independently extracting and reviewing data. There
were challenges in reaching out to experts to identify grey litera-
ture and when requesting additional data from the retrieved arti-
cles or published abstracts, which could have led to the omission
of relevant on-going studies. Due to lack of time, resource (finan-
cial and expertise) and facilities for translation, we could only
screen and include studies published and written in English
language.
Future work
To advance the science of future studies relating to ADL disabil-
ity, we encourage researchers and clinicians to work towards a
consensus on the definition of disability to influence more uniform
measurement of ADL disability.
We strongly advocate for the use of standardised, validated
instruments over local variations. Use of validated tools which con-
sider ADLs, for example the Lawton IADL Scale or the Functional
Independence Measure, would allow data to be reliably compared
across future studies and populations. We suggest that subjective
measures of dependency used as proxies for disability, or simply
summing the number of ADLs that require assistance, does not
portray the full nature or extent of ADL related disability. Future
research in this field could consider the degree of difficulty, type
and level of assistance required to perform specific activities.
Finally, intervention studies targeting the maintenance of ADL in
people living with cancer, including advanced and progressive dis-
ease, should select valid and sensitive scales to help identify,
develop and evaluate the best approaches.
Conclusions
This systematic review has identified the nature and prevalence
of ADL related disability in adults living with cancer. Overall, about
one-third and half of adults with cancer respectively have difficulty
or require assistance to perform basic and instrumental ADLs
across both inpatient and outpatients settings. Our findings pro-
vide useful insights for health care professionals to plan and deli-
ver rehabilitation services, and highlight a particular need for
rehabilitation focused on functional independence. The most fre-
quently affected ADLs were personal hygiene, walking and trans-
fers, housework, and shopping and transportation. This
understanding can help clinicians focus attention and anticipate
problems on activities most commonly affected by cancer. Our
findings also underscore the importance of professionals skilled
in occupational assessment and therapy in cancer care.
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